AUG 4, 2026 · PHASE 1 TRIAL
Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors
ClinicalTrials.gov
Phase 1 dose-escalation trial with completed enrollment but no efficacy or safety results reported in this registry record; evidence of tolerability and MTD cannot be assessed without posted outcomes.
Reported
Planned enrollment18
Trial phasePhase 1
Primary outcome measure 1dose limiting toxicity (DLT)